Kreikemeyer B, Martin D R, Chhatwal G S
GBF-National Research Center for Biotechnology, Technical University Braunschweig, Germany.
FEMS Microbiol Lett. 1999 Sep 15;178(2):305-11. doi: 10.1111/j.1574-6968.1999.tb08692.x.
Serum opacity factor (SOF) is produced by group A streptococci belonging to certain M types. SOF cleaves the apolipoprotein component of the high density lipoprotein fraction of serum rendering it insoluble which in turn leads to serum opacity. SfbII protein, a fibronectin binding surface protein cloned from group A streptococci, was obtained from a strain of M75. Here we show that this protein has a second functional domain responsible for SOF activity. The fibronectin binding region was located in the C-terminal end of the protein. Deletion analysis showed that the remainder of the protein was required for SOF activity. Sequence analysis of SfbII, when compared with the published sequence of SOF22, showed 99% identity with a difference of only four amino acids. In spite of this high homology, SOF from M75 was type-specific and antibody evoked specifically inhibited only SOF produced by M75. Antibodies found in human serum following natural infection also inhibited the SOF of SfbII in a type-specific manner. The results showed that the SfbII protein from M75 is SOF with a high serotype-specific enzyme activity.
血清混浊因子(SOF)由属于某些M型的A组链球菌产生。SOF可切割血清高密度脂蛋白部分的载脂蛋白成分,使其不溶,进而导致血清混浊。SfbII蛋白是一种从A组链球菌中克隆出的纤连蛋白结合表面蛋白,取自M75菌株。在此我们表明,该蛋白具有负责SOF活性的第二个功能域。纤连蛋白结合区域位于该蛋白的C末端。缺失分析表明,该蛋白的其余部分对于SOF活性是必需的。将SfbII的序列分析与已发表的SOF22序列进行比较时,发现两者有99%的同一性,仅四个氨基酸不同。尽管有这种高度同源性,但来自M75的SOF具有型特异性,所诱发的抗体仅特异性抑制M75产生的SOF。自然感染后人血清中发现的抗体也以型特异性方式抑制SfbII的SOF。结果表明,来自M75的SfbII蛋白是具有高血清型特异性酶活性的SOF。